☆ 4.6 Article

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore

CANCERS (2023)

Related references

Note: Only part of the references are listed.

Article Virology

IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues

Suzanne M. Garland et al.

Summary: It is advised to use only clinically validated HPV assays that have met internationally accepted performance criteria for primary cervical screening. Furthermore, the assays should be demonstrated to be suitable for use in the specific laboratory where they will be performed, and the availability of quality materials manuals and frameworks can be helpful in this process. Importantly, there is a fundamental shortage of well-validated, low-cost, low-complexity HPV tests that have demonstrated utility in a near-patient setting, posing a significant challenge and emphasizing the need for future development to achieve the WHO's goal of cervical cancer elimination.

JOURNAL OF CLINICAL VIROLOGY (2023)

Add to Collection

Article Public, Environmental & Occupational Health

Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative

Deependra Singh et al.

Summary: Tracking progress and providing evidence are essential for countries to achieve the WHO's goal of eliminating cervical cancer. This study assessed global inequalities in cervical cancer incidence and mortality based on the GLOBOCAN 2020 estimates, considering geographical and socioeconomic factors.

LANCET GLOBAL HEALTH (2023)

Add to Collection

Article Oncology

Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China

Xiang Tao et al.

Summary: The study found that extended high-risk human papillomavirus genotype testing for women with ASC-US cytology allows for risk stratification, which can optimize the efficiency of triage for hrHPV-positive women.

CANCER CYTOPATHOLOGY (2022)

Add to Collection

Article Oncology

Clinical Performance of the BD Onclarity Extended Genotyping Assay for the Management of Women Positive for Human Papillomavirus in Cervical Cancer Screening

Karena D. Volesky et al.

Summary: The study found near perfect concordance between the BD Onclarity HPV Assay and Roche's Linear Array for individual genotypes, regardless of viral load, in women testing positive for hrHPV. The most effective triage strategies for detecting CIN3+ among hrHPV positive women were positivity for HPV16 and/or 31 and HPV16 and/or 18, indicating the importance of HPV31 in triage of women positive for hrHPV.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Worldwide use of HPV self-sampling for cervical cancer screening

B. Serrano et al.

Summary: Self-sampling for HPV screening is increasingly recognized as a valid alternative to clinician collection, reaching underscreened women effectively. The global use of HPV self-sampling is currently limited, but efforts are being made to increase its adoption in the coming years. The COVID-19 pandemic has accelerated the introduction of HPV self-sampling as a key element in expanding screening coverage.

PREVENTIVE MEDICINE (2022)

Add to Collection

Article Pathology

Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program

Ditte Moller Ejegod et al.

Summary: The study confirmed that the Onclarity-COR instrument meets international validation criteria in terms of sensitivity, specificity, and laboratory reproducibility, making it suitable for cervical cancer screening.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

HPV prevention and control-The way forward

Alex Vorsters et al.

Summary: The COVID-19 pandemic has created opportunities for HPV prevention and control, but also poses potential public health threats. Existing resources and experiences should be utilized to continue promoting HPV vaccination and testing to prevent HPV-related cancers.

PREVENTIVE MEDICINE (2022)

Add to Collection

Article Virology

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology

Ian N. Hampson

Summary: Vaccination programs with HPV vaccines have been proven effective in preventing HPV infection and related diseases. Reductions in vaccine-covered HPV types have also been observed in unvaccinated women, but the effects of vaccine-associated HPV type-replacement are still unclear.

VIRUSES-BASEL (2022)

Add to Collection

Article Pathology

The Clinical Utility of Extended High-Risk HPV Genotyping in Women With ASC-US Cytology A Large Retrospective Study From Southwest China

Wei Jiang et al.

Summary: Extended hrHPV genotyping for women with ASC-US cytology could identify hrHPV genotypes associated with higher risk of CIN2+ and allows for refined risk stratification of women being screened.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2022)

Add to Collection

Article Oncology

Precancerous cervical lesions caused by non-vaccine- preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial

Jaimie Z. Shing et al.

Summary: A long-term follow-up study was conducted to evaluate the efficacy of HPV vaccination against cervical intraepithelial neoplasia caused by non-preventable HPV types. The study found that clinical unmasking could attenuate the long-term effectiveness of HPV vaccination in reducing high-grade diseases. However, the net benefit of vaccination for cervical cancer prevention is still considerable.

LANCET ONCOLOGY (2022)

Add to Collection

Review Public, Environmental & Occupational Health

Which is the best management for women with normal cervical cytologic findings despite positivity for non-16/18 high risk human papillomaviruses?

Ming Wu et al.

Summary: Women who are HPV positive but have normal cytology are the main focus of screening after HPV vaccination. The distribution of HPV genotypes has changed significantly and managing these women with normal cytology, non-HPV16/18 infections, or persistent infections has become uncertain. Current recommendations include retesting and surveillance, but these are not always applicable. Different triage strategies should be considered to detect high-grade cervical lesions, such as p16/Ki67 cytology assay and genotyping.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Health care provider's experience and perspective of cervical cancer screening in Singapore: A qualitative study

Brandon Wen Bing Chua et al.

Summary: Healthcare providers in Singapore face multiple challenges in delivering cervical cancer screening. The findings of this study are directly relevant and useful for developing policies around national cervical cancer screening programs and treatment guidelines.

FRONTIERS IN PUBLIC HEALTH (2022)

Add to Collection

Article Medicine, General & Internal

HPV Tests Comparison in the Detection and Follow-Up after Surgical Treatment of CIN2+ Lesions

Fabio Bottari et al.

Summary: This study evaluated the performance of six HPV DNA tests and one mRNA test in detecting cervical intraepithelial lesions (CIN) and as a test-of-cure in follow-up after surgical conservative treatment. The results showed that these tests had good concordance with HC2 and a very good and comparable sensitivity in CIN2+ detection.

DIAGNOSTICS (2022)

Add to Collection

Review Medicine, Research & Experimental

Human Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer

Patricia Pina-Sanchez

Summary: Viruses, as the most abundant and genetically diverse entities on Earth, have evolved along with their hosts and infect all life forms. Human papillomavirus (HPV), the main virus associated with cancer, can be eradicated as a global public health problem through early detection, prophylactic vaccines, and improved screening strategies.

ARCHIVES OF MEDICAL RESEARCH (2022)

Add to Collection

Article Obstetrics & Gynecology

Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program

Diede L. Loopik et al.

Summary: This study compared the effectiveness of the new high-risk human papillomavirus-based cervical cancer screening program with the previous cytology-based screening program in the Netherlands. The findings showed that high-risk human papillomavirus-based screening can increase the detection of high-grade cervical intraepithelial neoplasia, but also comes with a higher risk of overdiagnosis.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Add to Collection

Article Economics

Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia

Michael L. Ganz et al.

Summary: The study showed that in patients with TD, treatment with valbenazine was more cost-effective compared to deutetrabenazine, leading to higher response rates, longer lifespan, and increased quality-adjusted life years (QALYs).

JOURNAL OF MEDICAL ECONOMICS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007-2018: A retrospective cohort study

Meijuan Li et al.

Summary: In women in Guangdong, HPV52, 58, 68, and 39 are more likely to cause infection and be persistent. Incidence and persistence rates of HPV are higher in younger and older women compared to middle-aged women. The period of HPV retesting may impact the detection of HPV incidence, persistence and clearance.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2021)

Add to Collection

Review Infectious Diseases

2020 list of human papillomavirus assays suitable for primary cervical cancer screening

Marc Arbyn et al.

Summary: This study updated the list of high-risk HPV assays that fulfill the international validation criteria, with only 11 DNA assays meeting the requirements for cervical cancer screening using clinician-collected specimens, while other tests partially fulfilled the validation criteria.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Editorial Material Immunology

Are We Facing a New Colposcopic Practice in the HPV Vaccination Era? Opportunities, Challenges, and New Perspectives

Ankica Lukic et al.

Summary: The combination of primary and secondary prevention has influenced colposcopic practice, prompting proposed strategies for maintaining diagnostic accuracy through patient risk stratification and the application of artificial intelligence. Italy's strong colposcopic tradition calls for more accredited colposcopists to adapt to the vaccination era.

VACCINES (2021)

Add to Collection

Article Immunology

Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore

Lee Cheng Phua et al.

Summary: This study evaluated the cost-effectiveness of replacing the bivalent HPV vaccine with the nonavalent HPV vaccine in the national school-based HPV vaccination program in Singapore. Results showed that the nonavalent vaccine had an ICER of S$61,629 per quality-adjusted life year gained in the base case, indicating that it may not be a cost-effective option compared to the bivalent vaccine for school-based HPV vaccination of 13-year old female students in Singapore. Considerable price reductions would be necessary to justify its inclusion in the school-based program in the future.

VACCINE (2021)

Add to Collection

Article Economics

Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories

J. Jaime Caro et al.

Summary: This study utilizes individual simulation tools to assist in planning hospital resources for managing COVID-19 patients, modeling the occupancy of ward and critical care beds. A case study for Guy's and St Thomas' Trust is provided, showcasing the correlation between forecasts and actual data.

VALUE IN HEALTH (2021)

Add to Collection

Review Obstetrics & Gynecology

The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis

Diede L. Loopik et al.

Summary: The study aimed to provide an updated overview of regression, persistence, and progression rates of conservatively managed CIN 1/CIN 2/CIN 3. Most CIN 1/CIN 2 cases will regress spontaneously in less than 24 months, with the highest regression rates seen in high-risk HPV-negative and young women, while progression to cancer is less than 0.5%. Conservative management may be considered, especially in fertile women with expected high compliance.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2021)

Add to Collection

Article Medicine, General & Internal

Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040)

Yung-Taek Ouh et al.

Summary: This study identified age and HPV genotypes as factors responsible for discrepancies between cervical cytology and histology. It is recommended to take precautions for women over the age of 45 in triage for colposcopy to avoid unnecessary testing.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Add to Collection

Article Infectious Diseases

The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually

Lindsey Asti et al.

Summary: The study found that under specific conditions, extended genotyping is cost-effective and even cost saving compared to current tests. The key driver of cost-effectiveness is the risk of disease progression, emphasizing the need for a better understanding of these risks in different populations.

SEXUALLY TRANSMITTED DISEASES (2021)

Add to Collection

Article Obstetrics & Gynecology

Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review

Jesper Bonde et al.

Summary: The study examines the association between high-grade CIN and HPV SGTP versus GS, supporting the clinical utility of SGTP for risk discrimination in high-grade CIN.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2021)

Add to Collection

Letter Medicine, General & Internal

COVID-19 and health care workers burnout: A call for global action

Dharam Kaushik

ECLINICALMEDICINE (2021)

Add to Collection

Article Microbiology

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework

Jesper Hansen Bonde et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Add to Collection

Article Economics

Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France

Salah Ghabri et al.

VALUE IN HEALTH (2020)

Add to Collection

Article Oncology

Impact of HPV vaccination on cervical screening performance: a population-based cohort study

Jiayao Lei et al.

BRITISH JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention

Maisa Pinheiro et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Extended HPV Genotyping to Compare HPV Type Distribution in Self- and Provider-Collected Samples for Cervical Cancer Screening

Eliane Rohner et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Add to Collection

Article Pharmacology & Pharmacy

Using Discretely Integrated Condition Event Simulation To Construct Quantitative Benefit-Risk Models: The Example of Rotavirus Vaccination in France

Hugo Arlegui et al.

CLINICAL THERAPEUTICS (2020)

Add to Collection

Article Economics

Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid Models

J. Jaime Caro et al.

VALUE IN HEALTH (2020)

Add to Collection

Article Health Care Sciences & Services

The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China

Diling Pan et al.

RISK MANAGEMENT AND HEALTHCARE POLICY (2020)

Add to Collection

Review Oncology

Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature

Carlo A. Liverani et al.

JOURNAL OF ONCOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs

Maria Demarco et al.

ECLINICALMEDICINE (2020)

Add to Collection

Article Obstetrics & Gynecology

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Rebecca B. Perkins et al.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2020)

Add to Collection

Article Immunology

Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine

Andreas Ahrlund-Richter et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Add to Collection

Article Virology

High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program

Hugo Sousa et al.

PAPILLOMAVIRUS RESEARCH (2019)

Add to Collection

Article Oncology

The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results

Mark H. Stoler et al.

GYNECOLOGIC ONCOLOGY (2018)

Add to Collection

Article Oncology

Impact of HPV vaccination on outcome of cervical cytology screening in Denmark-A register-based cohort study

Lise Holst Thamsborg et al.

INTERNATIONAL JOURNAL OF CANCER (2018)

Add to Collection

Article Oncology

Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix

Louise De Brot et al.

CANCER CYTOPATHOLOGY (2017)

Add to Collection

Article Medical Laboratory Technology

Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings

Eun-Hee Nah et al.

ANNALS OF LABORATORY MEDICINE (2017)

Add to Collection

Article Oncology

Quality of life in long-term and very long-term cancer survivors versus population controls in Germany

Volker Arndt et al.

ACTA ONCOLOGICA (2017)

Add to Collection

Article Oncology

Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study

S. Rachel Skinner et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

Add to Collection

Review Virology

VALGENT: A protocol for clinical validation of human papillomavirus assays

Marc Arbyn et al.

JOURNAL OF CLINICAL VIROLOGY (2016)

Add to Collection

Article Economics

Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics

J. Jaime Caro

PHARMACOECONOMICS (2016)

Add to Collection

Article Health Care Sciences & Services

Introduction

Henry C. Kitchener et al.

HEALTH TECHNOLOGY ASSESSMENT (2014)

Add to Collection

Article Immunology

Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study

Sun Kuie Tay et al.

INTERNATIONAL JOURNAL OF STD & AIDS (2014)

Add to Collection

Article Multidisciplinary Sciences

Meta-Analysis on Prevalence and Attribution of Human Papillomavirus Types 52 and 58 in Cervical Neoplasia Worldwide

Paul K. S. Chan et al.

PLOS ONE (2014)

Add to Collection

Article Obstetrics & Gynecology

Health-related quality of life and perception of anxiety in women with abnormal cervical cytology referred for colposcopy: an observational study

Annu Heinonen et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)

Add to Collection

Article Oncology

Human Papillomavirus Type Distribution in Invasive Cervical Cancer and High-Grade Cervical Intraepithelial Neoplasia Across 5 Countries in Asia

Swee Chong Quek et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)

Add to Collection

Article Obstetrics & Gynecology

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Hormuzd A. Katki et al.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)

Add to Collection

Article Obstetrics & Gynecology

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+After a Colposcopic Diagnosis of CIN 1 or Less

Hormuzd A. Katki et al.

JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)

Add to Collection

Article Economics

Modeling Good Research Practices-Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1

J. Jaime Caro et al.

VALUE IN HEALTH (2012)

Add to Collection

Article Infectious Diseases

Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women

A. Pista et al.

CLINICAL MICROBIOLOGY AND INFECTION (2011)

Add to Collection

Article Oncology

Comparison of Measurements of Human Papillomavirus Persistence for Postcolposcopic Surveillance for Cervical Precancerous Lesions

Julia C. Gage et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Add to Collection

Article Immunology

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

Mark Schiffman et al.

Infectious Agents and Cancer (2009)

Add to Collection

Article Medicine, General & Internal

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

Philip E. Castle et al.

BMJ-BRITISH MEDICAL JOURNAL (2009)

Add to Collection

Article Obstetrics & Gynecology

A longitudinal study of sexual functioning in women referred for colposcopy: a 2-year follow up

C. Hellsten et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)

Add to Collection

Article Health Care Sciences & Services

Abnormal outcomes following cervical cancer screening: Event duration and health utility loss

Ralph P. Insinga et al.

MEDICAL DECISION MAKING (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.